Graves' disease following allogenic hematopoietic stem cell transplantation for severe aplastic anemia: case report and literature review

Paketci A., DEMİR K., TÜFEKÇİ Ö., Acar S., ABACI A., YILMAZ Ş., ...Daha Fazla

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.31, sa.5, ss.589-593, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 31 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1515/jpem-2017-0358
  • Dergi Adı: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.589-593
  • Anahtar Kelimeler: allogenic hematopoietic stem cell transplantation, Graves' disease, hyperthyroidism, severe aplastic anemia, BONE-MARROW-TRANSPLANTATION, ANTITHYMOCYTE GLOBULIN, IN-VITRO, THYROTOXICOSIS, CHILDHOOD, RECIPIENT, OUTCOMES, HORSE, DONOR
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Similar autoimmune processes (defective T-cell function) take place during the pathogenesis of aplastic anemia (AA) and Graves' disease (GD). Antithyroid drugs used for the management of GD may induce AA and GD may occur following treatment of severe aplastic anemia (SAA).